Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0733-2022

Drug recall · April 6, 2022

TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil recall

Why: Lack of sterility assurance.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi dose 10ml vial, Formula ID 115498, APS Pharmacy

Lots / codes

Lot:759312 BUD: 8/30/2022

Quantity
0
Company
Drug Depot, Inc., dba APS Pharmacy, Palm Harbor, FL
Distribution
Nationwide in the USA including Puerto Rico.
Initiated
March 23, 2022 · Voluntary: Firm initiated
Classified
March 29, 2022
Reported
April 6, 2022
Ended
October 5, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Testosterone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.